It is recognized that well-defined ADP-ribosylated
peptides and analogues thereof could help further the
research on ADP-ribosylation.6 Recently we have
reported the synthesis of mono-ADP-ribosylated pep-
tides, in which ADP-ribose is linked to a peptide via
an asparagine or glutamine residue.7 Others have pre-
pared oxime linked analogues of mono-ADP-ribosyl
peptides.8 To enable the future synthesis of ADP-ribosyl
derivatives containing more than one adenosine dipho-
sphate ribose residue (see Figure 1, n > 0), the avail-
ability of a suitably protected ribosylated adenosine
building block is crucial. Synthetic challenges in the
construction of such a building block are the formation
of the R-glycosidic bond between the anomeric center
of ribofuranose and the 20-hydroxyl of adenosine, and
the design of a suitable, orthogonal protective group
strategy.
O-Glycosylated nucleosides in general are difficult to
synthesize.9,18 The nucleobase is often more reactive as a
nucleophile than the intended hydroxyl. As a result side
reactions at the nucleobase may occur that can lead, in the
case of purines, to depurination of the nucleoside. Conse-
quently, yields are often low for such glycosylation reac-
tions.9 Shimofuridin,10,11 bearing a 20-O-β-fucopyranosyl
moiety, and adenophostin,12ꢀ14 bearing a 30-O-R-gluco-
pyranosyl moiety, are two examples of glycosylated
nucleoside analogues, in which the nucleosides are equ-
ipped with pyranosyl moieties. Although several nucleo-
sides decorated with O-β-linked furanosyl groups have
been synthesized,15ꢀ18 there is only one reported synthesis
of 20-O-R-ribosylated adenosine.19 This reported proce-
dure involves a 1,2-trans selective coupling of arabinofur-
anose to adenosine, assisted by the 20-O-acyl group,
followed by inversion of the stereochemistry at the 2-posi-
tion of the arabinofuranose via an oxidationꢀreduction
protocol.19
In order to synthesize 20-O-R-ribosylated adenosine with
orthogonal protective groups on the primary hydroxyl
functions, we considered an approach involving R-glyco-
sylation of adenosine with a suitable ribofuranosyl donor
to be most convenient. We opted to use 2,3,5-tri-O-benzyl-
D-ribofuranose since it is known from literature that non-
participating benzyl protection on the ribofuranosyl donor
in glycosylation reactions allows formation of mainly or
exclusively the R-riboside.20ꢀ22 In contrast, 2,3-isopr-
opylidene23 or 2,3-benzylidene24 protection, which would
also be convenient protection groups due to the ease of
introduction and cleavage, leads to anomeric mixtures,
while application of acyl based protective groups would
result in exclusive formation of the unwanted β-riboside
due to neighboring group participation. The high propen-
sity for R-substitution of benzylated ribofuranosyl donors
can be satisfactorily explained by the model advanced
by Woerpel for nucleophilic attack on five-membered
oxocarbenium ions.22 It is accepted that such an oxocar-
benium ion is a possible intermediate in Lewis acid pro-
moted nucleophilic substitution on furanosyl donors.25,26
Alternative explanations of the predisposition of ribofur-
anosyl donors, equipped with nonparticipating protec-
tions, to couple with high R-selectivity have also been
offered.21,27
Having selected the donor, we chose 3,5-OTIPDS pro-
tected N6-benzoyl adenosine 2 as the most suitable accep-
tor in this glycosylation (see Scheme 1).28 Since adenosine
may depurinate under strongly acidic conditions,29 we
considered that a mild glycosylation protocol would
be required. Based on this reasoning we first attempted
the procedure ofMukaiyama, who revealedthat activation
of 1 (see Scheme 1) with diphosphonium salts and ensuing
base-assisted glycosylation resulted in high yielding and R-
selective ribofuranosylation of unhindered alcohols.21
However, when we used sterically demanding compound
2 as the acceptor under the reported conditions no product
was formed.30 When we performed the glycosylation with
a larger excess of base a product different from the
expected compound 4 was formed. The NMR data of
the isolated product were consistent with 5, in which 2,3,
5-tri-O-Bn-ribofuranose was R-coupled to the N-1 of
adenosine. Apparently, the excess of base increases the
(6) Lin, H. Org. Biomol. Chem. 2007, 5, 2541–2554.
(7) van der Heden van Noort, G. J.; van der Horst, M. G.; Overkleeft,
H. S.; van der Marel, G. A.; Filippov, D. V. J. Am. Chem. Soc. 2010, 132,
5236–5240.
(8) Moyle, P. M.; Muir, T. W. J. Am. Chem. Soc. 2010, 132,
15878–15880.
(9) Knapp, S.; Gore, V. K. J. Org. Chem. 1996, 61, 6744–6747.
(18) Efimtseva, E. V.; Kulikova, I. V.; Mikhailov, S. N. Curr. Org.
Chem. 2007, 11, 337–354.
(20) Uchiro, H.; Mukaiyama, T. Chem. Lett. 1996, 271–272.
(21) Mukaiyama, T.; Suda, S. Chem. Lett. 1990, 1143–1146.
(22) Larsen, C. H.; Ridgway, B. H.; Shaw, J. T.; Smith, D. M.;
Woerpel, K. A. J. Am. Chem. Soc. 2005, 127, 10879–10884.
(23) Hirano, S.; Ichikawa, S.; Matsuda, A. J. Org. Chem. 2007, 72,
9936–9946.
(10) Kobayashi, J.; Doi, Y.; Ishibashi, M. J. Org. Chem. 1994, 59,
255–257.
(11) Ning, J.; Xing, Y.; Kong, F. Carbohydr. Res. 2003, 338, 55–60.
(12) van Straten, N. C. R.; van der Marel, G. A.; van Boom, J. H.
Tetrahedron 1997, 53, 6509–6522.
(13) Borissow, C. N.; Black, S. J.; Paul, M.; Tovey, S. C.; Dedos,
S. G.; Taylor, C. W.; Potter, B. V. L. Org. Biomol. Chem. 2005, 3,
245–252.
(24) Takahashi, H.; Isobe, M.; Goto, T. Tetrahedron 1991, 47,
6215–6222.
(25) Rhoad, J. S.; Cagg, B. A.; Carver, P. W. J. Phys. Chem. A 2010,
114, 5180–5186.
(26) Stalford, S. A.; Kilner, C. A.; Leach, A. G.; Turnbull, W. B. Org.
Biomol. Chem. 2009, 7, 4842–4852.
(27) Prevost, M.; St-Jean, O.; Guindon, Y. J. Am. Chem. Soc. 2010,
132, 12433–12439.
(28) Markiewicz, W. T. J. Chem. Res., Synop. 1979, 24–25.
(29) van der Heden van Noort, G. J.; Overkleeft, H. S.; van der
Marel, G. A.; Filippov, D. V. J. Org. Chem. 2010, 75, 5733–5736.
(30) When we adopted this procedure for the glycosylation of 3,5-
OTIPDS protected uridine, we observed formation of 20-O-(2,3,
5-O-Bn-R-ribosyl)uridine, however in low yield (15%).
(14) Sureshan, K. M.; Trusselle, M.; Tovey, S. C.; Taylor, C. W.;
Potter, B. V. L. J. Org. Chem. 2008, 73, 1682–1692.
(15) Mikhailov, S. N.; Efimtseva, E. V.; Gurskaya, G. V.; Fomitcheva,
M. V.; Meshkov, S. V. J. Carbohydr. Chem. 1997, 16, 75–92.
(16) Efimtseva, E. V.; Bobkov, G. V.; Mikhailov, S. N.; Van
Aerschot, A.; Schepers, G.; Busson, R.; Rozenski, J.; Herdewijn, P.
Helv. Chim. Acta 2001, 84, 2387–2397.
(17) Andreeva, O. I.; Golubeva, A. S.; Kochetkov, S. N.; Van
Aerschot, A.; Herdewijn, P.; Efimtseva, E. V.; Ermolinsky, B. S.;
Mikhailov, S. N. Bioorg. Med. Chem. Lett. 2002, 12, 681–684.
(19) Mikhailov, S. N.; Kulikova, I. V.; Nauwelaerts, K.; Herdewijn,
P. Tetrahedron 2008, 64, 2871–2876.
Org. Lett., Vol. 13, No. 11, 2011
2921